| Key Financial Ratios of Bliss GVS Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
8.02 |
7.23 |
6.83 |
1.46 |
6.64 |
|
| Diluted EPS (Rs.) |
7.95 |
7.11 |
6.72 |
1.43 |
6.49 |
|
| Cash EPS (Rs.) |
11.36 |
10.31 |
9.16 |
3.90 |
8.84 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
99.68 |
95.80 |
88.08 |
81.64 |
80.27 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
99.68 |
95.80 |
88.08 |
81.64 |
80.27 |
|
| Revenue from Operations/Share (Rs.) |
76.85 |
73.57 |
72.16 |
72.09 |
55.96 |
|
| PBDIT/Share (Rs.) |
15.49 |
17.13 |
12.97 |
14.45 |
12.30 |
|
| PBIT/Share (Rs.) |
12.69 |
14.61 |
11.18 |
12.78 |
10.63 |
|
| PBT/Share (Rs.) |
11.92 |
11.16 |
10.18 |
5.22 |
10.10 |
|
| Net Profit/Share (Rs.) |
8.57 |
7.79 |
7.37 |
2.23 |
7.17 |
|
| NP After MI And SOA / Share (Rs.) |
8.00 |
7.21 |
6.80 |
1.45 |
6.64 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
20.15 |
23.28 |
17.97 |
20.04 |
21.98 |
|
| PBIT Margin (%) |
16.51 |
19.86 |
15.49 |
17.72 |
18.99 |
|
| PBT Margin (%) |
15.51 |
15.17 |
14.11 |
7.24 |
18.03 |
|
| Net Profit Margin (%) |
11.14 |
10.59 |
10.20 |
3.09 |
12.81 |
|
| NP After MI And SOA Margin (%) |
10.41 |
9.79 |
9.42 |
2.01 |
11.86 |
|
| Return on Networth/Equity (%) |
8.02 |
7.80 |
8.01 |
1.83 |
8.47 |
|
| Return on Capital Employed (%) |
11.84 |
14.51 |
12.08 |
15.13 |
12.55 |
|
| Return on Assets (%) |
6.48 |
6.21 |
6.12 |
1.35 |
6.36 |
|
| Total Debt/Equity (X) |
0.07 |
0.09 |
0.11 |
0.13 |
0.12 |
|
| Asset Turnover Ratio (%) |
0.64 |
0.65 |
0.53 |
0.59 |
0.47 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
4.81 |
5.08 |
3.61 |
3.33 |
3.76 |
|
| Quick Ratio (X) |
4.08 |
4.34 |
3.08 |
2.80 |
3.27 |
|
| Inventory Turnover Ratio (X) |
6.57 |
3.06 |
2.96 |
3.71 |
2.73 |
|
| Dividend Payout Ratio (NP) (%) |
6.22 |
6.90 |
7.32 |
34.41 |
7.52 |
|
| Dividend Payout Ratio (CP) (%) |
4.61 |
5.11 |
5.79 |
15.98 |
6.01 |
|
| Earnings Retention Ratio (%) |
93.78 |
93.10 |
92.68 |
65.59 |
92.48 |
|
| Cash Earnings Retention Ratio (%) |
95.39 |
94.89 |
94.21 |
84.02 |
93.99 |
|
| Coverage Ratios |
|
|
|
|
|
|
| Interest Coverage Ratios (%) |
20.10 |
25.95 |
13.04 |
31.60 |
23.01 |
|
| Interest Coverage Ratios (Post Tax) (%) |
20.10 |
25.95 |
13.04 |
31.60 |
23.01 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,137.76 |
1,087.33 |
770.70 |
752.99 |
990.81 |
|
| EV/Net Operating Revenue (X) |
1.41 |
1.41 |
1.03 |
1.01 |
1.72 |
|
| EV/EBITDA (X) |
6.97 |
6.06 |
5.70 |
5.03 |
7.81 |
|
| MarketCap/Net Operating Revenue (X) |
1.53 |
1.53 |
0.99 |
1.07 |
1.76 |
|
| Retention Ratios (%) |
93.77 |
93.09 |
92.67 |
65.58 |
92.47 |
|
| Price/BV (X) |
1.18 |
1.22 |
0.84 |
0.97 |
1.26 |
|
| Price/Net Operating Revenue |
1.53 |
1.53 |
0.99 |
1.07 |
1.76 |
|
| Earnings Yield |
0.07 |
0.06 |
0.10 |
0.02 |
0.07 |
|
Source : Dion Global Solutions Limited
